Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder

References

• Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD, Organization WH. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020: summary.  World Health Organization, 1996.
   Google Scholar
• Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–2223.
   PubMed Web of Science ®Google Scholar
• Üstün TB, Ayuso-Mateos JL, Chatterji S, et al. Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004;184(5):386–392.
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–2196.
   PubMed Web of Science ®Google Scholar
• Whiteford HA, Ferrari AJ, Degenhardt L, et al. The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010. PloS One. 2015;10(2):e0116820.
   PubMed Web of Science ®Google Scholar
• Smit F, Cuijpers P, Oostenbrink J, et al. Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ. 2006;9(4):193-200.
   PubMed Web of Science ®Google Scholar
• Sobocki P, Jönsson B, Angst J, et al. Cost of depression in Europe. J Ment Health Policy Econ. 2006;9(2):87–98.
   PubMed Web of Science ®Google Scholar
• Cuijpers P, van Straten A, Andersson G, et al. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol. 2008;76(6):909.
   PubMed Web of Science ®Google Scholar
• Cuijpers P, van Straten A, van Schaik A, et al. Psychological treatment of depression in primary care: a meta-analysis. Br J Gen Pract. 2009;59(559):e51–e60.
   PubMed Web of Science ®Google Scholar
• Cuijpers P, Karyotaki E, de Wit L, et al. The effects of fifteen evidence-supported therapies for adult depression: a meta-analytic review. Psychother Res. 2020;30(3):279–293.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Salanti G, Furukawa TA, et al. Antidepressants might work for people with major depression: where do we go from here? Lancet Psychiatry. 2018;5(6):461–463.
   PubMed Web of Science ®Google Scholar
• Cuijpers P, Noma H, Karyotaki E, et al. A network meta‐analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry. 2020;19(1):92–107.
   PubMed Web of Science ®Google Scholar
• Cuijpers P, van Straten A, Smit F, et al. Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions. Am J Psychiatry. 2008;165(10):1272–1280.
   PubMed Web of Science ®Google Scholar
• van Zoonen K, Buntrock C, Ebert DD, et al. Preventing the onset of major depressive disorder: a meta-analytic review of psychological interventions. Int J Epidemiol. 2014 Apr;43(2):318–329.
   PubMed Web of Science ®Google Scholar
• Vos T, Carter R, Barendregt J, et al. Assessing cost-effectiveness in prevention: ACE–prevention September 2010 final report. University of Queensland; 2010.
   Google Scholar
• Chisholm D. Choosing cost-effective interventions in psychiatry: results from the CHOICE programme of the World Health Organization. World Psychiatry. 2005;4(1):37.
   PubMedGoogle Scholar
• Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. Oxford, UK: Oxford university press; 2015.
   Google Scholar
• Roberts M, Russell LB, Paltiel AD, et al. Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force–2. Med Decis Mak. 2012;32(5):678–689.
   PubMed Web of Science ®Google Scholar
• GGZ guidelines. Multidisciplinary guideline for depression, second revision. Utrecht: Trimbos Institute; 2011.
   Google Scholar
• Bijl R, Van Zessen G, Ravelli A, et al. The Netherlands mental health survey and incidence study (NEMESIS): objectives and design. Soc Psychiatry Psychiatr Epidemiol. 1998;33(12):581–586.
   PubMed Web of Science ®Google Scholar
• Bijl RV, de Graaf R, Ravelli A, et al. Gender and age-specific first incidence of DSM-III-R psychiatric disorders in the general population. Soc Psychiatry Psychiatr Epidemiol. 2002;37(8):372–379.
   PubMed Web of Science ®Google Scholar
• de Graaf R, Ten Have M, Tuithof M, et al. First-incidence of DSM-IV mood, anxiety and substance use disorders and its determinants: results from the Netherlands Mental Health Survey and Incidence Study-2. J Affect Disord. 2013;149(1–3):100–107.
   PubMed Web of Science ®Google Scholar
• Spijker J, de Graaf R, Bijl RV, et al. Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry. 2002 Sep;181:208–213.
   PubMed Web of Science ®Google Scholar
• Spijker J, De Graaf R, Bijl R, et al. Functional disability and depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS. Acta Psychiatr Scand. 2004;110(3):208–214.
   PubMed Web of Science ®Google Scholar
• Vos T, Haby MM, Barendregt JJ, et al. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry. 2004;61(11):1097–1103.
   PubMed Web of Science ®Google Scholar
• Stouthard ME, Essink-Bot M, Bonsel G, et al. Disability weights for diseases in the Netherlands. Department of Public Health, Erasmus University Rotterdam, the Netherlands. 1997.
   Google Scholar
• Sanderson K, Andrews G, Corry J, et al. Using the effect size to model change in preference values from descriptive health status. Qual Life Res. 2004;13(7):1255–1264.
   PubMed Web of Science ®Google Scholar
• Hakkaart-van Roijen L, Van der Linden N, Bouwmans C, et al. Kostenhandleiding. In: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg In opdracht van Zorginstituut Nederland Geactualiseerde versie. Zorginstituut Nederland, Diemen, the Netherlands. 2015.
   Google Scholar
• Van Hout BA, Al MJ, Gordon GS, et al. Costs, effects and C/E‐ratios alongside a clinical trial. Health Econ. 1994;3(5):309–319.
   PubMed Web of Science ®Google Scholar
• Naimark DM, Bott M, Krahn M. The half-cycle correction explained: two alternative pedagogical approaches. Med Decis Mak. 2008;28(5):706–712.
   PubMed Web of Science ®Google Scholar
• Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000 Feb;157(2):229–233.
   PubMed Web of Science ®Google Scholar
• Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford, UK: OUP Oxford; 2006.
   Google Scholar
• de Graaf R, Ten Have M, van Gool C, et al. Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2. Soc Psychiatry Psychiatr Epidemiol. 2012;47(2):203–213.
   PubMed Web of Science ®Google Scholar
• Chisholm D, Sanderson K, Ayuso-Mateos JL, et al. Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry. 2004;184(5):393–403.
   PubMedGoogle Scholar
• Voor de Statistiek CB. Levensverwachting; geslacht, leeftijd (per jaar en periode van vijf jaren). 2018. Available from: https://opendata.cbs.nl/statline/#/CBS/nl/dataset/37360ned/table?
   Google Scholar
• Lokkerbol J, Adema D, Cuijpers P, et al. Improving the cost-effectiveness of a healthcare system for depressive disorders by implementing telemedicine: a health economic modeling study. Am J Geriatric Psychiatry. 2014;22(3):253–262.
   PubMed Web of Science ®Google Scholar
• Karyotaki E, Riper H, Twisk J, et al. Efficacy of self-guided internet-based cognitive behavioral therapy in the treatment of depressive symptoms: a meta-analysis of individual participant data. JAMA Psychiatry. 2017;74(4):351–359.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of antidepressant drugs in the acute treatment of major depressive disorder: a network meta-analysis. Lancet. 2018;391:1357–1366.
   PubMed Web of Science ®Google Scholar
• Vittengl JR, Clark LA, Dunn TW, et al. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy’s effects. J Consult Clin Psychol. 2007;75(3):475.
   PubMed Web of Science ®Google Scholar
• Biesheuvel-Leliefeld KE, Kok GD, Bockting CL, et al. Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and meta-regression. J Affect Disord. 2015;174:400–410.
   PubMed Web of Science ®Google Scholar
• Doyle JJ, Casciano J, Arikian S, et al. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost‐effectiveness between venlafaxine, SSRIs and TCAs. Value Health. 2001;4(1):16–31.
   PubMedGoogle Scholar
• Nuijten MJ, Hardens M, Souêtre EA. Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression. Pharmacoeconomics. 1995;8(2):159–168.
   PubMed Web of Science ®Google Scholar
• Paulden M, Palmer S, Hewitt C, et al. Screening for postnatal depression in primary care: cost effectiveness analysis. BMJ. 2009;339:b5203.
   PubMedGoogle Scholar
• Simpson KN, Welch MJ, Kozel FA, et al. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis. Adv Ther. 2009;26(3):346–368.
   PubMed Web of Science ®Google Scholar
• Wells KB, Schoenbaum M, Duan N, et al. Cost-effectiveness of quality improvement programs for patients with subthreshold depression or depressive disorder. Psychiatric Serv. 2007;58(10):1269–1278.
   PubMed Web of Science ®Google Scholar
• van der Aa HP, van Rens GH, Bosmans JE, et al. Economic evaluation of stepped-care versus usual care for depression and anxiety in older adults with vision impairment: randomized controlled trial. BMC Psychiatry. 2017;17(1):280.
   PubMedGoogle Scholar
• Lynch FL, Hornbrook M, Clarke GN, et al. Cost-effectiveness of an intervention to prevent depression in at-risk teens. Arch Gen Psychiatry. 2005;62(11):1241–1248.
   PubMed Web of Science ®Google Scholar
• Fernández A, Mendive JM, Conejo-Cerón S, et al. A personalized intervention to prevent depression in primary care: cost-effectiveness study nested into a clustered randomized trial. BMC Med. 2018;16(1):28.
   PubMedGoogle Scholar
• Kessler RC. The costs of depression. Psychiatr Clinics. 2012;35(1):1–14.
   PubMed Web of Science ®Google Scholar
• Wojnarowski C, Firth N, Finegan M, et al. Predictors of depression relapse and recurrence after cognitive behavioural therapy: a systematic review and meta-analysis. Behav Cogn Psychother. 2019;47(5):514–529.
   PubMed Web of Science ®Google Scholar
• Mihalopoulos C, Magnus A, Lal A, et al. Is implementation of the 2013 Australian treatment guidelines for posttraumatic stress disorder cost-effective compared to current practice? A cost-utility analysis using QALYs and DALYs. Aust N Z J Psychiatry. 2015;49(4):360–376.
   PubMed Web of Science ®Google Scholar